Variant report
Variant | nsv10254 |
---|---|
Chromosome Location | chr3:24661741-24666296 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554251001 | chr3:24661745-24661746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574403382 | chr3:24661756-24661757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563601700 | chr3:24661798-24661799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530808981 | chr3:24661800-24661801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs59446401 | chr3:24661809-24661810 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs570633667 | chr3:24661811-24661812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9842833 | chr3:24661888-24661889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148718697 | chr3:24661897-24661898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181215462 | chr3:24661930-24661931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535482463 | chr3:24661939-24661940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556663583 | chr3:24661941-24661942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78416610 | chr3:24661951-24661952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568889123 | chr3:24661981-24661982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112941897 | chr3:24662021-24662022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115142981 | chr3:24662032-24662033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs56218990 | chr3:24662056-24662057 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs541256159 | chr3:24662083-24662084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553478453 | chr3:24662166-24662167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112441782 | chr3:24662181-24662182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139292568 | chr3:24662213-24662214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17014979 | chr3:24662241-24662242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577129881 | chr3:24662259-24662260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184924156 | chr3:24662274-24662275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546072676 | chr3:24662481-24662482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564284234 | chr3:24662482-24662483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7625506 | chr3:24662556-24662557 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs546477223 | chr3:24662569-24662570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6767114 | chr3:24662611-24662612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568177692 | chr3:24662656-24662657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528967187 | chr3:24662668-24662669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73042404 | chr3:24662714-24662715 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs116650812 | chr3:24662717-24662718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188220558 | chr3:24662726-24662727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558860367 | chr3:24662768-24662769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73820024 | chr3:24662813-24662814 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs73042405 | chr3:24662818-24662819 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs116422288 | chr3:24662845-24662846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73042407 | chr3:24662854-24662855 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs75515441 | chr3:24662877-24662878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557395850 | chr3:24662887-24662888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541955528 | chr3:24662915-24662916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116827509 | chr3:24662918-24662919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140201731 | chr3:24662954-24662955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540457175 | chr3:24662975-24662976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114811317 | chr3:24662981-24662982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143898003 | chr3:24663045-24663046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78390722 | chr3:24663070-24663071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149034953 | chr3:24663084-24663085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532810493 | chr3:24663100-24663101 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569373694 | chr3:24663118-24663119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24658800-24667000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr3:24660800-24664400 | Weak transcription | Fetal Intestine Small | intestine |
3 | chr3:24662800-24663600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr3:24662800-24664000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr3:24662800-24665400 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr3:24662800-24666000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr3:24663600-24664800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr3:24663600-24665600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr3:24663800-24666400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr3:24664400-24664600 | Enhancers | Fetal Intestine Small | intestine |
11 | chr3:24664600-24665000 | Weak transcription | Fetal Intestine Small | intestine |
12 | chr3:24664800-24666000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr3:24664800-24666200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr3:24665000-24665400 | Enhancers | Fetal Intestine Small | intestine |
15 | chr3:24665000-24665600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr3:24665000-24665800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr3:24665600-24665800 | Bivalent Enhancer | Fetal Kidney | kidney |
18 | chr3:24665600-24666200 | Enhancers | H9 Cell Line | embryonic stem cell |
19 | chr3:24666200-24667200 | Weak transcription | H9 Cell Line | embryonic stem cell |